RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
T2 Biosystems Stock

T2 Biosystems Net Income 2024

T2 Biosystems Net Income

-55.27 M USD

Ticker

TTOO

ISIN

US89853L1044

WKN

A119H3

In 2024, T2 Biosystems's profit amounted to -55.27 M USD, a 10.37% increase from the -50.08 M USD profit recorded in the previous year.

The T2 Biosystems Net Income history

YEARNET INCOME (undefined USD)
2029e-
2028e-
2027e-
2026e-
2025e-
2024e-
2023-
2022-
2021-
2020-
2019-
2018-
2017-
2016-
2015-
2014-
2013-
2012-

T2 Biosystems Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into T2 Biosystems, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by T2 Biosystems from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects T2 Biosystems’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of T2 Biosystems. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into T2 Biosystems’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing T2 Biosystems’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on T2 Biosystems’s growth potential.

T2 Biosystems Revenue, EBIT and net profit per share

DateT2 Biosystems RevenueT2 Biosystems EBITT2 Biosystems Net Income
2029e80.07 M undefined0 undefined-3.92 M undefined
2028e62.22 M undefined-33.76 M undefined-6.6 M undefined
2027e47.12 M undefined-41.62 M undefined-9.98 M undefined
2026e33.97 M undefined-38.05 M undefined-12.48 M undefined
2025e23.56 M undefined-39.58 M undefined-21.22 M undefined
2024e10.81 M undefined-42.23 M undefined-55.27 M undefined
20237.19 M undefined-47.15 M undefined-50.08 M undefined
202222.31 M undefined-55.2 M undefined-62.33 M undefined
202128.06 M undefined-42.97 M undefined-49.24 M undefined
202018.13 M undefined-40.26 M undefined-46.8 M undefined
20198.34 M undefined-52.06 M undefined-59.01 M undefined
201810.5 M undefined-45.09 M undefined-51.15 M undefined
20174.67 M undefined-53.85 M undefined-62.43 M undefined
20164.08 M undefined-50.88 M undefined-54.8 M undefined
20152.81 M undefined-43.38 M undefined-45.29 M undefined
2014120,000 undefined-30.68 M undefined-35.96 M undefined
2013270,000 undefined-19.69 M undefined-27.52 M undefined
201220,000 undefined-14.65 M undefined-18.87 M undefined

T2 Biosystems stock margins

The T2 Biosystems margin analysis displays the gross margin, EBIT margin, as well as the profit margin of T2 Biosystems. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for T2 Biosystems.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the T2 Biosystems's sales revenue. A higher gross margin percentage indicates that the T2 Biosystems retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the T2 Biosystems's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the T2 Biosystems's total revenue generated. When comparing the revenue margin year over year, investors can gauge the T2 Biosystems's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the T2 Biosystems. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the T2 Biosystems's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

T2 Biosystems Margin History

T2 Biosystems Gross marginT2 Biosystems Profit marginT2 Biosystems EBIT marginT2 Biosystems Profit margin
2029e-113.58 %0 %-4.9 %
2028e-113.58 %-54.26 %-10.6 %
2027e-113.58 %-88.31 %-21.19 %
2026e-113.58 %-112.01 %-36.74 %
2025e-113.58 %-167.97 %-90.05 %
2024e-113.58 %-390.57 %-511.21 %
2023-113.58 %-655.54 %-696.19 %
20225.38 %-247.42 %-279.38 %
202126.23 %-153.14 %-175.48 %
2020-14.07 %-222.06 %-258.14 %
2019-101.08 %-624.22 %-707.55 %
2018-46.67 %-429.43 %-487.14 %
2017-157.6 %-1,153.1 %-1,336.83 %
2016-68.38 %-1,247.06 %-1,343.14 %
201538.08 %-1,543.77 %-1,611.74 %
2014-113.58 %-25,566.67 %-29,966.67 %
2013-113.58 %-7,292.59 %-10,192.59 %
2012-113.58 %-73,250 %-94,350.01 %

T2 Biosystems Aktienanalyse

What does T2 Biosystems do?

T2 Biosystems Inc. is an American company that was founded in 2006. The company is based in Lexington, Massachusetts. The founders of T2 Biosystems aimed to create an innovative diagnostic system that could improve hospital performance. Their business model is based on the development, manufacturing, and distribution of innovative instruments and diagnostic solutions. T2 Biosystems operates in various sectors, with a focus on diagnosis and healthcare solutions. The key areas are: 1. Infectious diseases: T2 Biosystems develops systems that enable rapid and accurate diagnosis of infectious diseases in hospitals and other medical facilities. The team has already made significant progress in detecting infections such as sepsis, pneumonia, and other diseases that require prompt diagnosis to increase patient survival rates. 2. Hematology: The company has also developed a product called T2HemoStat, which improves accuracy in determining biomarkers in blood samples. HemoStat allows for real-time analysis of patient samples to achieve faster results than current standard tests. 3. Healthcare: T2 Biosystems also offers solutions to improve healthcare. The goal is to address issues in healthcare by using data and information more intelligently. The company is working on products tailored to the needs of hospitals and healthcare providers. T2 Biosystems pursues a collaborative strategy, fostering cooperation among clinics, customers, and companies. T2 Biosystems has successfully launched several products, including the T2Dx instrument, which enables rapid and accurate detection of infections. The measurement system is based on T2 Magnetic Resonance (T2MR) technology, which can identify cells and biomolecules based on magnetic resonance. The T2Dx system is also capable of identifying drugs directly in the tests, allowing for better utilization of antibiotics to combat resistant bacteria. In collaboration with Harvard Medical School, the company is also working on developing specific tests focused on the detection of bacteria or viruses. The team at T2 Biosystems has developed an innovative system that allows for the analysis of bacterial or viral strains. T2 Biosystems has a rapidly growing customer base and is a key player in the healthcare market. The company has already established important partnerships with some of the leading hospitals in the US and continues to work on forming further partnerships in other parts of the world. The products of T2 Biosystems have received numerous awards, including the "Best of Show" prize at the Association of Clinical Chemistry Annual Meeting and the "Medical Device Excellence Award" from the Massachusetts Medical Device Industry Council. The company operates in a highly competitive market. To remain competitive, T2 Biosystems heavily invests in research and development. The company also has a strong presence on social media to raise awareness of their products and services. T2 Biosystems aims to achieve further medical advancements and develop innovative technologies to improve patient care in the future. T2 Biosystems ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Net Income Details

Understanding T2 Biosystems's Profit Margins

The profit margins of T2 Biosystems represent the net income earned after deducting all operational expenses, costs, and taxes from the revenue. This figure is a clear indicator of T2 Biosystems's financial health, operational efficiency, and profitability. Higher profit margins signify better cost management and income generation capabilities.

Year-to-Year Comparison

Evaluating T2 Biosystems's profit on a yearly basis can offer significant insights into its financial growth, stability, and trends. A consistent increase in profit suggests improved operational efficiency, cost management, or increased revenue, while a decrease may indicate rising costs, declining sales, or operational challenges.

Impact on Investments

T2 Biosystems's profit figures are critical for investors who are aiming to understand the company's financial standing and future growth prospects. Increased profits often lead to higher stock valuations, boosting investor confidence and attracting more investments.

Interpreting Profit Fluctuations

When T2 Biosystems’s profit increases, it often indicates enhanced operational efficiency or increased sales. In contrast, a decline in profit can signal operational inefficiencies, increased costs, or competitive pressures, necessitating strategic interventions to boost profitability.

Frequently Asked Questions about T2 Biosystems stock

How much profit has T2 Biosystems made this year?

T2 Biosystems has made -55.27 M USD this year.

How has the profit developed compared to last year?

The profit has increased by 10.37% compared to last year increased

What impact do the earnings have on the shareholders?

An increase in earnings is usually seen as a positive indicator for shareholders as it means that the company is generating profits.

How does T2 Biosystems publish its earnings?

T2 Biosystems publishes its earnings in the form of quarterly or annual reports.

Which financial indicators are included in the quarterly or annual reports?

The quarterly or annual reports contain information about sales and profit, cash flow, balance sheet, and other fundamentals.

Why is it important for investors to know the earnings of T2 Biosystems?

The profits of T2 Biosystems are an important indicator of the financial health of the company and can help investors decide whether they want to invest in the company or not.

How can one learn more about the earnings of T2 Biosystems?

You can learn more about the earnings of T2 Biosystems by reviewing the quarterly or annual reports or following the company presentations.

How much dividend does T2 Biosystems pay?

Over the past 12 months, T2 Biosystems paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, T2 Biosystems is expected to pay a dividend of 0 USD.

What is the dividend yield of T2 Biosystems?

The current dividend yield of T2 Biosystems is .

When does T2 Biosystems pay dividends?

T2 Biosystems pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of T2 Biosystems?

T2 Biosystems paid dividends every year for the past 0 years.

What is the dividend of T2 Biosystems?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is T2 Biosystems located?

T2 Biosystems is assigned to the 'Health' sector.

Wann musste ich die Aktien von T2 Biosystems kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of T2 Biosystems from 10/6/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 10/6/2024.

When did T2 Biosystems pay the last dividend?

The last dividend was paid out on 10/6/2024.

What was the dividend of T2 Biosystems in the year 2023?

In the year 2023, T2 Biosystems distributed 0 USD as dividends.

In which currency does T2 Biosystems pay out the dividend?

The dividends of T2 Biosystems are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von T2 Biosystems

Our stock analysis for T2 Biosystems Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of T2 Biosystems Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.